Search Results - "Sánchez Zapardiel, Elena"
-
1
The challenge of standardizing CAR‐T cell monitoring: A comparison of two flow‐cytometry methods and correlation with qPCR technique
Published in Cytometry. Part A (01-05-2024)“…Chimeric antigen receptor (CAR) T‐cell therapy is a breakthrough in hematologic malignancies, such as acute B lymphoblastic leukemia (B‐ALL). Monitoring this…”
Get full text
Journal Article -
2
Epstein-Barr virus-specific T-cell response in pediatric liver transplant recipients: a cross-sectional study by multiparametric flow cytometry
Published in Frontiers in immunology (24-10-2024)“…Epstein-Barr virus (EBV) specific T-cell response measurement can help adjust immunosuppression in transplant patients with persistent infections. We aim to…”
Get full text
Journal Article -
3
Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience
Published in Frontiers in immunology (23-11-2022)“…Immune responses to vaccines against severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2 are variable. In the absence of disease, youngsters are…”
Get full text
Journal Article -
4
CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation
Published in Frontiers in immunology (08-08-2022)“…Treatment targeting CD19 by a chimeric antigen receptor expressed on T cells (anti-CD19 CAR-T) has led to a breakthrough in the management and treatment of…”
Get full text
Journal Article -
5
Isolated De Novo Antiendothelial Cell Antibodies and Kidney Transplant Rejection
Published in American journal of kidney diseases (01-12-2016)“…Background Studies analyzing the role of antiendothelial cell antibodies (AECAs) in large series of kidney transplant recipients are scarce, and HLA, MHC…”
Get full text
Journal Article -
6
Familial CD45RA - T cells to treat severe refractory infections in immunocompromised patients
Published in Frontiers in medicine (08-02-2023)“…Immunocompromised patients are susceptible to high-risk opportunistic infections and malignant diseases. Most antiviral and antifungal drugs are quite toxic,…”
Get full text
Journal Article -
7
Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3
Published in Clinical transplantation (01-01-2017)“…Complement component 3 (C3) presents both slow (C3S) and fast (C3F) variants, which can be locally produced and activated by immune system cells. We studied C3…”
Get full text
Journal Article -
8
Suppression of anoikis by collagen coating of interconnected macroporous nanometric carbonated hydroxyapatite/agarose scaffolds
Published in Journal of biomedical materials research. Part A (01-12-2010)“…Three dimensional interconnected macroporous (pore diameter: 600–800 μm) hydroxyapatite/agarose disks have been evaluated in this study as potential bone…”
Get full text
Journal Article -
9
Severe Impairment of T-cell Immunity and Pulmonary GvHD Are Major Risk Factors for Nontuberculous Mycobacterial Infection After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
Published in The Pediatric infectious disease journal (01-09-2024)“…Hematopoietic stem cell transplant recipients are prone to infectious complications. Infections caused by nontuberculous mycobacteria have increased in adults…”
Get full text
Journal Article -
10
Failure of Viral-Specific T Cells Administered in Pre-transplant Settings in Children with Inborn Errors of Immunity
Published in Journal of clinical immunology (01-05-2021)“…Purpose Use of adoptive immunotherapy with virus-specific T cells (VST) in patients with inborn errors of immunity prior to hematopoietic stem cell…”
Get full text
Journal Article -
11
Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity
Published in Nephrology, dialysis, transplantation (01-01-2016)“…We previously reported that preformed anti-MHC class I-related chain A (MICA) antibodies increase the risk for renal graft rejection and enhance the…”
Get full text
Journal Article -
12
Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 ( CASP10 ) variation
Published in Immunobiology (1979) (01-01-2016)“…Abstract Autoimmune lymphoproliferative syndrome (ALPS) is a primary immunodeficiency caused by impaired Fas/FasL-mediated apoptosis of lymphocytes and is…”
Get full text
Journal Article -
13
A case‐control study to assess the role of polyomavirus in transplant complications: Where do we stand?
Published in Transplant infectious disease (01-12-2020)“…Purpose The study's aim was to assess whether polyomavirus DNAemia screening was associated with different outcomes in patients with positive viremia compared…”
Get full text
Journal Article -
14
Harmful Effect of Preformed Anti-MICA Antibodies on Renal Allograft Evolution in Early Posttransplantation Period
Published in Transplantation (15-07-2013)“…BACKGROUNDPretransplantation anti–major histocompatibility complex class I chain–related molecule A (MICA) sensitization is an uncommon event and its role on…”
Get full text
Journal Article -
15
Blockade of cell adhesion molecules enhances cell engraftment in a murine model of liver cell transplantation
Published in Transplant immunology (01-03-2016)“…Abstract Aim OLT is the best alternative for patients with end-stage liver diseases. However, as the need for organs surpasses donor availability, alternatives…”
Get full text
Journal Article -
16
Mes de nacimiento, HLA-DRB1 y riesgo de esclerosis múltiple en la descendencia
Published in Revista de neurologiá (2016)Get full text
Journal Article -
17
Breaking Barriers in B-Acute Lymphoblastic Leukemia Treatment: Experience of a Tertiary Hospital with the Use of a Tandem Dual CAR-T 19/22 in Pediatric & AYA Patients
Published in Blood (02-11-2023)“…INTRODUCTION Anti-CD19 chimeric antigen receptor (CAR) autologous T-cell therapy tisagenlecleucel (CTL019) has shown efficacy in pivotal trials and real-world…”
Get full text
Journal Article -
18
-
19
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Published in Cytotherapy (Oxford, England) (01-01-2024)“…There are currently no effective anti-viral treatments for coronavirus disease 2019 (COVID-19)-hospitalized patients with hypoxemia. Lymphopenia is a biomarker…”
Get full text
Journal Article -
20
Month of birth, HLA-DRB115 locus and risk of multiple sclerosis in offspring
Published in Revista de neurologiá (01-09-2016)“…A relationship among April births, HLA-DRB1*15:01 genotype and risk of multiple sclerosis (MS) has been described. We aim to determine this association in our…”
Get full text
Journal Article